Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid Arthritis
Clinical trial NCT05460390 · TERMINATED
Trial details
- NCT number
- NCT05460390
- Sponsor
- Boston Medical Center
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2024-06-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.